Variable

Sample

Control

Study

Total

<37 GW

>37 GW

IL-6 (ng/ml)

Sample 1

4.97 ± 1.68

10.37 ± 2.2

10.95 ± 2.93

10.1 ± 1.8

P value

P1 < 0.0001

P3 = 0.256

Sample 2

7.2 ± 2.6

6.71 ± 1.7

8.72 ± 0.9

5.82 ± 1.1

P value

P1 = 0.326

P3 = 0.0001

P2 < 0.0001

P2 < 0.0001

P2 = 0.007

P2 < 0.0001

Change in relation to S1 level

Increase by 140% (IQR: 131 - 151)

Decrease by 32.6% (IQR: 19 - 46)

Decrease by 16% (IQR: 7 - 26)

Decrease by 37.2% (IQR: 32 - 50)

P value

P1 < 0.0001

P3 = 0.0001

TNF-α (ng/ml)

Sample 1

0.82 ± 0.19

1.44 ± 0.5

2.08 ± 0.3

1.15 ± 0.22

P value

P1 < 0.0001

P1 < 0.0001

Sample 2

0.98 ± 0.26

1.11 ± 0.45

1.68 ± 0.29

0.86 ± 0.23

P value

P1 = 0.117

P1 < 0.0001

P2 = 0.0008

P2 = 0.001

P2 = 0.001

P2 < 0.0001

Change in relation to S1 level

Increase by 114% (IQR: 110 - 129)

Decrease by 19% (IQR: 17 - 31)

Decrease by 18% (IQR: 14 - 21)

Decrease by 21% (IQR: 17 - 32)

P value

P1 < 0.0001

P1 = 0.041

IL-10 (ng/ml)

Sample 1

0.96 ± 0.25

1.98 ± 0.6

2.63 ± 0.34

1.69 ± 0.43

P value

P1 < 0.0001

P1 < 0.0001

Sample 2

1.25 ± 0.33

1.13 ± 0.6

1.96 ± 0.32

0.75 ± 0.15

P value

P1 = 0.255

P1 < 0.0001

P2 < 0.0001

P2 < 0.0001

P2 < 0.0001

P2 < 0.0001

Change in relation to S1 level

Increase by 129% (IQR: 115 - 141)

Decrease by 44% (IQR: 35 - 57)

Decrease by 31% (IQR: 16 - 35)

Decrease by 51% (IQR: 42 - 65)

P value

P1 < 0.0001

P1 < 0.0001